Clinical Trials Browser

Breast Neoplasms, Hand-Foot Syndrome

NCT06602167 2024-12-12

Electroacupuncture Combined With Self-administered Acupressure for the Prevention of Capecitabine-Associated Hand-Foot Syndrome

Phase NA Recruiting

220 enrolled

BreastGastrointestinal

Breast Neoplasms, Gastrointestinal Neoplasms, Hand-Foot Syndrome

NCT06583369 2024-09-04

The Efficacy and Safety of Liangxue Ointment in the Treatment of Hand-foot Syndrome Caused by VEGFR-TKI Drugs

Phase NA Recruiting

220 enrolled

DermatologicGenitourinary

Carcinoma, Renal Cell, Melanoma, Hand-Foot Syndrome

NCT06441513 2024-06-04

The Preventive Effect of Chemotherapy-induced Hand-foot Syndrome

Phase NA Recruiting

130 enrolled

Neoplasms, Hand-Foot Syndrome

NCT05755646 2024-05-24

WIn-HFS

Phase NA Completed

36 enrolled

Breast

Breast Neoplasms, Hand-Foot Syndrome

NCT05641246 2024-01-03

Effect of Topical Diclofenac on Clinical Outcome in Breast Cancer Patients Treated With Capecitabine

Phase 2 Completed

86 enrolled

Breast

Breast Neoplasms, Hand-Foot Syndrome

NCT04979078 2023-06-18

DermLight

Phase NA Recruiting

40 enrolled

Neoplasms, Hand-Foot Syndrome

NCT00767689 2023-06-15

Vitamin B6 Can Prevent Hand and Foot Syndrome in Cancer Patients Capecitabine Chemotherapy

Phase NA Terminated

6 enrolled

Hand-Foot Syndrome

NCT05327751 2022-04-14

HFS

Phase 3 Unknown

44 enrolled

Gastrointestinal

Colorectal Neoplasms, Hand-Foot Syndrome

NCT00751101 2020-10-05

Nicotine Patches in Reducing Hand-Foot Syndrome in Patients Who Are Receiving Capecitabine For Metastatic Breast Cancer

Phase 2 Terminated

24 enrolled 12 charts

Breast

Breast Neoplasms, Hand-Foot Syndrome

NCT01100463 2019-10-08

Study of 0.1% Uracil Topical Cream (UTC) for the Prevention of Hand-Foot Syndrome

Phase 1/2 Completed

18 enrolled

Breast

Breast Neoplasms, Hyaline Fibromatosis Syndrome, Hand-Foot Syndrome

NCT03612011 2019-09-06

OCRP

Phase 3 Completed

72 enrolled

Neoplasms, Hand-Foot Syndrome

NCT02794493 2019-07-25

Treatment of Hand and Foot Syndrome With Traditional Chinese Medicine Formula LC09 in Patients Who Are Receiving Capecitabine for Colorectal and/or Breast Cancer

Phase 3 Completed

156 enrolled

Hand-Foot Syndrome

NCT03173365 2019-01-09

BRIMOCAN

Phase 2 Terminated

2 enrolled

Hand-Foot Syndrome

NCT01918852 2018-03-14

SALTO

Phase 3 Completed

161 enrolled

Gastrointestinal

Neoplasm Metastasis, Colorectal Neoplasms, Hand-Foot Syndrome

NCT00486213 2015-09-24

Pyridoxine in Preventing Hand-Foot Syndrome Caused by Capecitabine in Patients With Cancer

Phase 3 Terminated

210 enrolled

Hand-Foot Syndrome

NCT01291628 2012-01-19

Prevention of Capecitabine Induced Hand and Foot Syndrome

Phase NA Unknown

10 enrolled

Neoplasms, Hand-Foot Syndrome

Clinical Trials

The Efficacy and Safety of Mecobalamin in the Prevention of Capecitabine Induced Hand Foot Syndrome

Electroacupuncture Combined With Self-administered Acupressure for the Prevention of Capecitabine-Associated Hand-Foot Syndrome

The Efficacy and Safety of Liangxue Ointment in the Treatment of Hand-foot Syndrome Caused by VEGFR-TKI Drugs

The Preventive Effect of Chemotherapy-induced Hand-foot Syndrome

WIn-HFS

Effect of Topical Diclofenac on Clinical Outcome in Breast Cancer Patients Treated With Capecitabine

DermLight

Vitamin B6 Can Prevent Hand and Foot Syndrome in Cancer Patients Capecitabine Chemotherapy

HFS

Nicotine Patches in Reducing Hand-Foot Syndrome in Patients Who Are Receiving Capecitabine For Metastatic Breast Cancer

Study of 0.1% Uracil Topical Cream (UTC) for the Prevention of Hand-Foot Syndrome

OCRP

Treatment of Hand and Foot Syndrome With Traditional Chinese Medicine Formula LC09 in Patients Who Are Receiving Capecitabine for Colorectal and/or Breast Cancer

BRIMOCAN

SALTO

Pyridoxine in Preventing Hand-Foot Syndrome Caused by Capecitabine in Patients With Cancer

Prevention of Capecitabine Induced Hand and Foot Syndrome